Remove Clinic Remove Disease Remove Health Science Remove Hospital
article thumbnail

How AI and Stroke Workflow Optimization Can Result in Significant Time Savings

Aidoc

AI’s Impact on Stroke Care Theoretically, most would agree that evidence exists about how AI can enhance stroke triage and directly impact treatment times by making clinical workflows more efficient with mobile image viewing and care coordination. Savardekar; Louisiana State University Health Sciences Center, Shreveport.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman. please insert video here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ultrasound shows ties between uterine fibroid risk, family history

AuntMinnie

Researchers led by Christine Langton, PhD, from the National Institute of Environmental Health Sciences in Research Triangle Park, NC, found that this trend was especially prevalent when mothers were diagnosed at a younger age. The women had no prior clinical diagnosis of fibroids at enrollment were available for analysis.

article thumbnail

Bracco Imaging Announces Publication of Data Reinforcing Efficacy, Safety of Gadopiclenol in Contrast-Enhanced MRI of Certain Body Regions

Imaging Technology

The results also follow those of the PICTURE clinical trial published in Investigative Radiology in May, 2023, which found the non-inferior quality of morphologic assessment of lesions of the brain and spine with VUEWAY compared with Gadavist. mmol/kg gadopiclenol (VUEWAY) with 0.1 mmol/kg versus a full dose of gadobutrol (0.1 mmol/kg). [i]

MRI 98
article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.

article thumbnail

AuntMinnie 2007: Gadolinium: A 'necessary factor' in the development of NSF?

AuntMinnie

Imagine going in for a diagnostic MRI scan and coming out with a progressive, irreversible, and potentially fatal disease. It certainly doesn't help matters that the disease has been linked to gadolinium-based contrast agents, a ubiquitous tool in the MR armamentarium. Louis hospital. In 2006 the U.S.

Disease 116
article thumbnail

The rise of theranostics: Part 2 -- Moving into communities

AuntMinnie

They're also mindful of the multiple dedicated teams required to build a theranostics clinic properly. Hope, vice chair of clinical operations and strategy in the UCSF department of radiology, established the radioligand therapy group at the university. Hope added. But prostate cancer will be different," Hope continued. "A